Ninety-Day Inhalation Toxicity Study With A Vapor Grown Carbon Nanofiber in Rats
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
A subchronic inhalation toxicity study of inhaled vapor grown carbon nanofibers (CNF) (VGCF-H) was conducted in male and female Sprague Dawley rats. The CNF test sample was composed of > 99.5% carbon with virtually no catalyst metals; Brunauer, Emmett, and Teller (BET) surface area measurements of 13.8 m2/g; and mean lengths and diameters of 5.8 µm and 158 nm, respectively.Four groups of rats per sex were exposed nose-only, 6 h/day, for 5 days/week to target concentrations of 0, 0.50, 2.5, or 25 mg/m3 VGCF-H over a 90-day period and evaluated 1 day later. Assessments included conventional clinical and histopathological methods, bronchoalveolar lavage fluid (BALF) analysis, and cell proliferation (CP) studies of the terminal bronchiole (TB), alveolar duct (AD), and subpleural regions of the respiratory tract. In addition, groups of 0 and 25 mg/m3 exposed rats were evaluated at 3 months postexposure (PE). Aerosol exposures of rats to 0.54 (4.9 f/cc), 2.5 (56 f/cc), and 25 (252 f/cc) mg/m(3) of VGCF-H CNFs produced concentration-related small, detectable accumulation of extrapulmonary fibers with no adverse tissue effects. At the two highest concentrations, inflammation of the TB and AD regions of the respiratory tract was noted wherein fiber-laden alveolar macrophages had accumulated. This finding was characterized by minimal infiltrates of inflammatory cells in rats exposed to 2.5mg/m(3) CNF, inflammation along with some thickening of interstitial walls, and hypertrophy/hyperplasia of type II epithelial cells, graded as slight for the 25mg/m(3) concentration. At 3 months PE, the inflammation in the high dose was reduced. No adverse effects were observed at 0.54mg/m(3). BALF and CP endpoint increases versus controls were noted at 25mg/m(3) VGCF-H but not different from control values at 0.54 or 2.5mg/m(3). After 90 days PE, BALF biomarkers were still increased at 25mg/m(3), indicating that the inflammatory response was not fully resolved. Greater than 90% of CNF-exposed, BALF-recovered alveolar macrophages from the 25 and 2.5mg/m(3) exposure groups contained nanofibers (> 60% for 0.5mg/m(3)). A nonspecific inflammatory response was also noted in the nasal passages. The no-observed-adverse-effect level for VGCF-H nanofibers was considered to be 0.54mg/m(3) (4.9 fibers/cc) for male and female rats, based on the minimal inflammation in the terminal bronchiole and alveolar duct areas of the lungs at 2.5mg/m(3) exposures. It is noteworthy that the histopathology observations at the 2.5mg/m(3) exposure level did not correlate with the CP or BALF data at that exposure concentration. In addition, the results with CNF are compared with published findings of 90-day inhalation studies in rats with carbon nanotubes, and hypotheses are presented for potency differences based on CNT physicochemical characteristics. Finally, the (lack of) relevance of CNF for the high aspect ratio nanomaterials/fiber paradigm is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donaldson, K., Aitken, R., Tran, L., Stone, V., Duffin, R., Forrest, G., & Alexander, A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj130 · Cited by 1,167 · cited 2×
“In the aggregate, the findings have fostered a toxicological concept known as the " fiber paradigm " principles , which have been built historically upon the well-described database for asbestos toxicity studies (Donaldson et al., 2006, 2011).”
BackgroundRespiratory toxicity of multi-wall carbon nanotubes
Muller, J., Huaux, F., Moreau, N., Misson, P., Heilier, J.-F., Delos, M., Arras, M., Fonseca, A., Nagy, J. B., & Lison, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.008 · Cited by 1,123 · cited 1×
“The pulmonary toxicity database for CNTs has rapidly emerged since the onset of the initial, intratracheal instillation studies with SWCNTs and MWCNTs were first reported in 2004–2005 (Lam et al., 2004; Muller et al., 2005; Warheit et al., 2004).”
BackgroundInhalation Toxicity of Multiwall Carbon Nanotubes in Rats Exposed for 3 Months
Ma-Hock, L., Treumann, S., Strauss, V., Brill, S., Luizi, F., Mertler, M., Wiench, K., Gamer, A. O., van Ravenzwaay, B., & Landsiedel, R. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp146 · Cited by 448
Sanchez, V. C., Pietruska, J. R., Miselis, N. R., Hurt, R. H., & Kane, A. B. (2009) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.41 · Cited by 186 · cited 1×
“effects in the lung, Sanchez et al. (2009), have suggested that CNT exposures”
Background
Cited by
The Toxicity of Nanoparticles Depends on Multiple Molecular and Physicochemical Mechanisms
Huang, Y.-W., Cambre, M., & Lee, H.-J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122702 · Cited by 415
Review of toxicity studies of carbon nanotubes
Kobayashi, N., Izumi, H., & Morimoto, Y. (2017) · Journal of Occupational Health · doi:10.1539/joh.17-0089-ra · Cited by 339
A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)
Arts, J. H. E., Hadi, M., Irfan, M.-A., Keene, A. M., Kreiling, R., Lyon, D., Maier, M., Michel, K., Petry, T., Sauer, U. G., et al. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.007 · Cited by 256
Self-citationInhalation Exposure to Carbon Nanotubes (CNT) and Carbon Nanofibers (CNF): Methodology and Dosimetry
Oberdörster, G., Castranova, V., Asgharian, B., & Sayre, P. (2015) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2015.1051611 · Cited by 150
Toxicity and bio-accumulation of inhaled cerium oxide nanoparticles in CD1 mice
Aalapati, S., Ganapathy, S., Manapuram, S., Anumolu, G., & Prakya, B. M. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.829877 · Cited by 141
Metadata
- Authors
- DeLorme, M. P., Muro, Y., Arai, T., Banas, D. A., Frame, S. R., Reed, K. L., & Warheit, D. B.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-10
- Volume
- 128
- Issue
- 2
- Pages
- 449-460
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2098826811
- Cited by
- 76
- References
- 4
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.